{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:48:15Z","timestamp":1790804895402,"version":"4.1.0"},"reference-count":41,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000},"content-version":"vor","delay-in-days":142,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["alz-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["A&amp;D Transl Res &amp; Clin Interv"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Digital technology is transforming the development of drugs for Alzheimer's disease and was the topic of the Alzheimer's Association's Research Roundtable on its May 23\u201324, 2017 meeting. Research indicates that wearable devices and unobtrusive passive sensors that enable the collection of frequent or continuous, objective, and multidimensional data during daily activities may capture subtle changes in cognition and functional capacity long before the onset of dementia. The potential to exploit these technologies to improve clinical trials as both recruitment and retention tools as well as for potential end points was discussed. The implications for the collection and use of large amounts of data, lessons learned from other related disease areas, ethical concerns raised by these new technologies, and regulatory issues were also covered in the meeting. Finally, the challenges and opportunities of these new technologies for future use were discussed.<\/jats:p>","DOI":"10.1016\/j.trci.2018.04.003","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T21:58:36Z","timestamp":1527112716000},"page":"234-242","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":128,"title":["Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials"],"prefix":"10.1002","volume":"4","author":[{"given":"Michael","family":"Gold","sequence":"first","affiliation":[{"name":"AbbVie Inc. North Chicago Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Amatniek","sequence":"additional","affiliation":[{"name":"Otsuka Pharmaceutical Development &amp; Commercialization, Inc. Princeton NJ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Carrillo","sequence":"additional","affiliation":[{"name":"Alzheimer's Association Chicago IL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse M.","family":"Cedarbaum","sequence":"additional","affiliation":[{"name":"Biogen Cambridge MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Hendrix","sequence":"additional","affiliation":[{"name":"Alzheimer's Association Chicago IL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley B.","family":"Miller","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company Indianapolis IN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Robillard","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Medicine University of British Columbia and Children's and Women's Hospital and Health Centres Vancouver BC Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Jeremy","family":"Rice","sequence":"additional","affiliation":[{"name":"Healthcare and Life Science Research, IBM T.J. Watson Research Center New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Soares","sequence":"additional","affiliation":[{"name":"AbbVie Inc. North Chicago Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria B.","family":"Tome","sequence":"additional","affiliation":[{"name":"European Medicines Agency (EMA) London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Tarnanas","sequence":"additional","affiliation":[{"name":"Altoida Inc. La Jolla CA USA"},{"name":"Scripps Memorial Hospital San Diego CA USA"},{"name":"Atlantic Fellow for Equity in Brain Health with the Global Brain Health Institute (GBHI) at UCSF San Francisco CA USA"},{"name":"Trinity College Dublin Dublin Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Vargas","sequence":"additional","affiliation":[{"name":"Early Development Amgen Thousand Oaks CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa J.","family":"Bain","sequence":"additional","affiliation":[{"name":"Independent Science Writer Elverson PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara J.","family":"Czaja","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Science Miller School of Medicine, University of Miami Miami FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,5,23]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.4524"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/0733464815570667"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1510774"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-130272"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318259e1de"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2008.07.004"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138095"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/geronb\/gbq095"},{"key":"e_1_2_12_10_1","first-page":"102","article-title":"Pervasive computing technologies to continuously assess Alzheimer's disease progression and intervention efficacy","volume":"7","author":"Lyons B.E.","year":"2015","journal-title":"Front Aging Neurosci"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadm.2015.09.006"},{"key":"e_1_2_12_12_1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fnagi.2017.00101","article-title":"Increased diagnostic accuracy of digital vs. conventional clock drawing test for discrimination of patients in the early course of Alzheimer's disease from cognitively healthy individuals","volume":"9","author":"Muller S.","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"e_1_2_12_13_1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1006\/brcg.2001.1377","article-title":"Distinct patterns of spontaneous speech deterioration: an early predictor of Alzheimer's disease","volume":"48","author":"Forbes K.E.","year":"2002","journal-title":"Brain Cogn"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bandl.2016.07.008"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2017.00269"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature12486"},{"key":"e_1_2_12_17_1","unstructured":"C.Leurent E.Pickering J.Goodman S.Duvvuri P.He E.Martucci et al.A Randomized Double\u2010Blind Placeo Controlled Trial to Study Difference in Cognitive Learning Associated with Repeated Self\u2010administration of Remote Computer Tablet\u2010based Application Assessing Dual Task Performance Based on Amyloid Status in Healthy Elderly Volunteers Clinical Trials in Alzheimer's Disease 9th conference; San Diego CA USA: J Prev Alz Dis2016;281"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadm.2015.10.005"},{"key":"e_1_2_12_19_1","unstructured":"Europe A. PharmaCog; 2011. Available at:http:\/\/www.alzheimer\u2010europe.org\/Research\/PharmaCog\/What\u2010is\u2010PharmaCog."},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2013.1314"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0000000000000016"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0000000000001205"},{"key":"e_1_2_12_23_1","first-page":"e51318","article-title":"The Multiple Sclerosis Performance Test (MSPT): an iPad\u2010based disability assessment tool","volume":"88","author":"Rudick R.A.","year":"2014","journal-title":"J Vis Exp"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458516688955"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a006873"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a033430"},{"key":"e_1_2_12_27_1","first-page":"19","article-title":"Report on ISCTM consensus meeting on clinical assessment of response to treatment of cognitive impairment in Schizophrenia","volume":"42","author":"Keefe R.S.","year":"2016","journal-title":"Schizophr Bull"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2016.03.038"},{"key":"e_1_2_12_29_1","unstructured":"Bionetworks S. PD Digital Biomarker DREAM Challenge; 2017."},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1147\/JRD.2017.2768739"},{"key":"e_1_2_12_31_1","volume-title":"Privacy Breach in B.C. Health Ministry Led to Freeze on Medical Research Data","author":"Hunter J.","year":"2016"},{"key":"e_1_2_12_32_1","doi-asserted-by":"crossref","DOI":"10.1145\/1525840.1525846","article-title":"Disability, age, and informationial privacy attitudes in quality of life technology applications: Results from a national web survey","volume":"2","author":"Beach S.","year":"2009","journal-title":"ACM Trans Access Comput"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadm.2015.03.004"},{"key":"e_1_2_12_34_1","first-page":"1154","article-title":"App\u2010synopsis \u2010 standard reporting for medical apps","volume":"192","author":"Albrecht U.V.","year":"2013","journal-title":"Stud Health Technol Inform"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/pra2.2015.145052010043"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.2196\/mhealth.6521"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1300\/J151v01n01_03"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2012.11.009"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trci.2016.09.001"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1177\/1049732309359171"},{"key":"e_1_2_12_41_1","unstructured":"European Medicines Agency. Clinical Trial Regulation; 2017. Available at:http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/regulation\/general\/general_content_000629.jsp."},{"key":"e_1_2_12_42_1","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S1474-4422(17)30223-5","article-title":"Diagnostic biomarkers for Alzheimer's disease: A regulatory view","volume":"16","author":"Isaac M.T.","year":"2017","journal-title":"Lancet Neurol"}],"container-title":["Alzheimer's &amp; Dementia: Translational Research &amp; Clinical Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352873718300210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352873718300210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1016\/j.trci.2018.04.003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1016\/j.trci.2018.04.003","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1016\/j.trci.2018.04.003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T11:23:24Z","timestamp":1761477804000},"score":1,"resource":{"primary":{"URL":"https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/10.1016\/j.trci.2018.04.003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1016\/j.trci.2018.04.003"],"URL":"https:\/\/doi.org\/10.1016\/j.trci.2018.04.003","archive":["Portico"],"relation":{},"ISSN":["2352-8737","2352-8737"],"issn-type":[{"value":"2352-8737","type":"print"},{"value":"2352-8737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"2018-05-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}